Power3 Medical Products, Inc. (PWRM.OB) Develops Alzheimer’s Breakthrough
Power3 Medical Products, Inc., www.power3medical.com – one of the foremost biotech operations specializing in cancer and neurodegenerative diagnostics, specifically Alzheimer’s, Parkinson’s and Lou Gehrig’s disease (amyotrophic lateral sclerosis or ALS), announced an amazing new breakthrough discovery today in conjunction with renown psychiatrist Lourdes R. Bosquez, MD. The Company’s leading Alzheimer’s diagnostic, NuroPro®, proved a hitherto unknown pharmaceutical ability to actually flag and track responses to drug treatment, as clinically distinct differences were detected in the response of NuroPro biomarkers in untreated patients when compared to those treated with the leading anti-dementia drugs Aricept® (Donepezil HCl, Pfizer), Exelon® (Rivastigmine, Novartis), and…